(Press-News.org) *Note: this paper is being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and is being published in The Lancet Microbe. Please credit both the congress and the journal in your stories*
A new study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Microbe, shows that antibodies generated by CoronaVac, an inactivated COVID-19 vaccine, work less well against the P.1 Brazil (Gamma) variant.
It also suggests that the P.1 variant may be able to reinfect individuals who previously had COVID-19.
The SARS-CoV-2 virus spike protein is the primary target of neutralising antibodies - antibodies that block the entry of the virus into cells - including those induced by vaccines. The emergence of variants with multiple mutations in this protein has raised concerns that neutralising antibody responses, and so the effectiveness of vaccination programmes, could be compromised.
The P.1 variant was discovered in Manaus, Brazil, in early January 2021 and has 15 unique mutations. Previous studies have found evidence that it can escape neutralisation by antibodies. However, most of these studies used modified viruses and there is little information on the ability of the wild-type P.1 variant, with a complete set of mutations, to evade neutralising antibodies in individuals previously infected with COVID-19 or vaccinated with an inactivated vaccine.
Dr Jose Luiz Proença-Módena, Laboratory of Emerging Viruses, University of Campinas, Brazil, and colleagues, studied the sensitivity of the P.1 variant to neutralising antibodies present in the serum of 53 individuals who had been vaccinated and 21 who had been previously infected with SARS-CoV-2.
The results were compared with those for a B lineage virus, one of the dominant strains in Brazil before the emergence of the P.1 variant.
The vaccinated group was made up of 18 individuals who had received a single dose and 20 who had received two doses of the CoronaVac inactivated vaccine during the Brazilian vaccination programme, plus 15 participants who had received two doses during a trial.
CoronaVac is one of the main vaccines in Brazil's national immunisation programme and has been approved for emergency use in Brazil, China, Columbia, Indonesia, Mexico and Turkey. Previous research from Brazil has shown it to be 50.7% effective at preventing symptomatic infections.
All the blood samples from individuals with past infections had high concentrations of SARS-CoV-2-specific antibodies. Tests showed the P.1 variant to be less sensitive to these antibodies than the B lineage virus. Antibody concentrations needed to be around nine times higher to neutralise the P.1 variant than the B lineage virus.
Antibodies from vaccinated individuals were also less efficient at neutralising the P.1 variant than the B lineage virus. The antibodies from almost all of the people who had one dose of the vaccine (20-23 days earlier) as part of the immunisation programme and all of those who had two doses in the trial (134-260 days earlier) had no detectable effect on the P.1 variant.
In contrast, the P.1 variant was still sensitive to the antibodies in the plasma of those who had two doses in the immunisation programme (second dose 17-38 days earlier) but to a lesser extent than the B lineage virus.
The authors say: "This study shows that antibodies present in the plasma of people with a history of COVID-19 or individuals vaccinated with CoronaVac were less efficient at neutralising P.1 variant isolates than a B lineage isolate.
"Neutralising antibodies are an important component of the immune response against SARS-CoV-2. Therefore, the capacity of the P.1 variant to evade antibodies present in the plasma of CoronaVac-immunised individuals suggests that the virus can potentially circulate in vaccinated individuals - even in areas with high vaccination rates."
They add: "Our results also suggest that the P.1 variant can escape from neutralising antibody responses generated by previous SARS-CoV-2 infection and thus reinfection might be possible.
"Consequently, continued and enhanced genetic surveillance of SARS-CoV-2 variants worldwide, paired with plasma neutralising antibody assays is required to guide updates of immunisation programmes.
"However, a phase 3 clinical trial showed that CoronaVac can protect against severe COVID-19 and death. Therefore, neutralising antibodies might not be the only contributing factor - the T-cell response may also play an important role in reducing disease severity."
INFORMATION:
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
The preliminary findings, published in The Lancet and presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), indicate that CoronaVac induces a robust antibody response. No severe adverse events or deaths were reported among the more than 10,000 trial participants in Turkey, with most adverse events mild and occurring within 7 days of an injection. However, more research is needed to confirm vaccine efficacy in the long term, in a more diverse group of participants, and against emerging variants of concern.
CoronaVac uses an inactivated whole virus. When people receive the vaccine, ...
Led by the London School of Hygiene & Tropical Medicine (LSHTM), in partnership with the World Health Organization (WHO) and Avenir Health, the research team carried out a systematic review and meta-analysis of syphilis prevalence among MSM between 2000 to 2020, drawing on data from 275 studies involving more than 600,000 study participants across 77 countries.
The worldwide prevalence of syphilis among MSM was 15x higher than most recent estimates for men in the general population (7.5% versus 0.5%). Researchers further estimated the prevalence across eight regions of the Sustainable Development Goals (SDG) and six regions of the WHO. Latin America and the Caribbean region had the highest prevalence of syphilis (10.6%), whereas Australia and New Zealand had the lowest (1.9%). ...
A new paper in Nature lays out the way natural ecosystems parallel U.S. supply chains and how American cities can use these tools to strengthen their supply chains.
The paper, "Supply chain diversity buffers cities against food shocks," is co-authored by Benjamin Ruddell, director of the FEWSION Project and the School of Informatics, Computing, and Cyber Systems at Northern Arizona University, and Richard Rushforth, an assistant research professor in SICCS, in collaboration with FEWSION project researchers at Penn State. FEWSION is an NSF-funded collaboration that uses comprehensive data mapping to monitor domestic supply chains for food, water and energy down to the county level.
This research looks at the importance of diversity within the ...
Remember Napster? The peer-to-peer file sharing company, popular in the late 1990s and early 2000s, depended on users sharing their music files. To promote cooperation, such software "could mislead its users," says Bryce Morsky, a postdoc in Penn's School of Arts & Sciences.
Some file-sharing companies falsely asserted that all of their users were sharing. Or, they displayed the mean number of files shared per user, hiding the fact that some users were sharing a great deal and many others were not. Related online forums promoted the idea that sharing was both ethical and the norm. ...
As light detection and ranging (lidar) technology evolves, forest ecology and ecological restoration researchers have been using these tools in a wide range of applications.
"We needed an accounting of relative accuracy and errors among lidar platforms within a range of forest types and structural configurations," said associate professor Andrew Sánchez Meador, executive director of NAU's Ecological Restoration Institute (ERI).
Sánchez Meador led a study recently published in Remote Sensing, "Adjudicating Perspectives on Forest Structure: How Do Airborne, ...
Hundreds of millions of years ago, in the middle of what would eventually become Canada's Yukon Territory, an ocean swirled with armored trilobites, clam-like brachiopods and soft, squishy creatures akin to slugs and squid.
A trove of fossils and rock layers formed on that ancient ocean floor have now been unearthed by an international team of scientists along the banks of the Peel River a few hundred miles south of the Arctic's Beaufort Sea. The discovery reveals oxygen changes at the seafloor across nearly 120 million years of the early Paleozoic era, a time that fostered the most rapid development and diversification of complex, multi-cellular life in Earth's history.
"It's unheard of to have that much of Earth's history in one place," said Stanford University geological ...
Our gut microbiome -- the ever-changing "rainforest" of bacteria living in our intestines -- is primarily affected by our lifestyle, including what we eat or the medications we take, most studies show.
But a University of Notre Dame study has found a much greater genetic component at play than was once known.
In the study, published recently in END ...
Nonprofits and companies planting trees in the tropics may often pick species for their commercial rather than ecological value, researchers found in a new analysis of organizations' publicly available data. They also found many may not have tracked the trees' survival.
Tree planting is a promising, but controversial, restoration strategy for fighting climate change. A new study in the journal Biological Conservation provides a detailed look at what restoration organizations across the tropics are actually doing on the ground.
"We found some organizations placed an emphasis on biological diversity and forest restoration in their mission statements. When we looked at the species they reported ...
Major ecosystem changes like sea-level rise, desertification and lake warming are fueling uncertainty about the future. Many initiatives - such as those fighting to fully eradicate non-native species, or to combat wildfires - focus on actively resisting change to preserve a slice of the past.
However, resisting ecosystem transformation is not always a feasible approach. According to a new paper published today in the Ecological Society of America's journal Frontiers in Ecology and the Environment, accepting and directing ecosystem change are also viable responses, and should not necessarily be viewed as fallback options or as last resorts. The paper presents a set of guiding principles for applying a "RAD" strategy - a framework that involves ...
BENGALURU, India (July 8, 2021) - A new study led by WCS-India documents how a big cat deity worshipped by Indigenous Peoples facilitates coexistence between humans and leopards.
The study, published in a special issue of the journal Frontiers in Conservation Science: Human-Wildlife Dynamics called Understanding Coexistence with Wildlife documents how the Indigenous Warli people of Maharashtra, India, worship Waghoba, a leopard/tiger deity to gain protection from leopards, and how they have lived side-by-side with them for centuries (formerly tigers, too). The researchers have identified over 150 shrines dedicated ...
